Arch Historical Income Statement

ARCH Stock  CAD 1.94  0.01  0.52%   
Historical analysis of Arch Biopartners income statement accounts such as Total Revenue of 2.4 M, Other Operating Expenses of 6.3 M or Cost Of Revenue of 1.3 M can show how well Arch Biopartners performed in making a profits. Evaluating Arch Biopartners income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Arch Biopartners's future profits or losses.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Arch Biopartners latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Arch Biopartners is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arch Biopartners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

About Arch Income Statement Analysis

Arch Biopartners Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Arch Biopartners shareholders. The income statement also shows Arch investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Arch Biopartners Income Statement Chart

At this time, Arch Biopartners' Depreciation And Amortization is fairly stable compared to the past year. Total Revenue is likely to climb to about 2.4 M in 2025, despite the fact that Operating Income is likely to grow to (4.5 M).

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Arch Biopartners. It is also known as Arch Biopartners overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Arch Biopartners' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Arch Biopartners current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arch Biopartners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
At this time, Arch Biopartners' Depreciation And Amortization is fairly stable compared to the past year. Total Revenue is likely to climb to about 2.4 M in 2025, despite the fact that Operating Income is likely to grow to (4.5 M).
 2021 2022 2024 2025 (projected)
Research Development1.3M2.2M2.5M2.7M
Interest Expense309.3K358.9K412.8K433.4K

Arch Biopartners income statement Correlations

0.32-0.50.91-0.93-0.97-0.920.540.91-0.890.64-0.88-0.090.56-0.020.610.64-0.97-0.560.61
0.320.360.48-0.44-0.36-0.430.80.48-0.250.61-0.210.15-0.13-0.370.830.87-0.29-0.820.62
-0.50.36-0.160.260.390.24-0.2-0.160.460.20.51-0.01-0.86-0.510.14-0.120.57-0.10.34
0.910.48-0.16-0.97-0.94-0.980.491.0-0.860.81-0.830.00.23-0.340.780.66-0.88-0.710.87
-0.93-0.440.26-0.970.981.0-0.55-0.970.92-0.750.890.0-0.30.27-0.74-0.660.930.71-0.79
-0.97-0.360.39-0.940.980.98-0.55-0.940.93-0.690.910.05-0.440.13-0.66-0.640.970.63-0.69
-0.92-0.430.24-0.981.00.98-0.53-0.980.91-0.760.880.01-0.280.28-0.74-0.640.920.71-0.8
0.540.8-0.20.49-0.55-0.55-0.530.49-0.490.44-0.480.170.34-0.040.710.94-0.58-0.770.35
0.910.48-0.161.0-0.97-0.94-0.980.49-0.860.81-0.830.00.22-0.340.780.66-0.88-0.710.87
-0.89-0.250.46-0.860.920.930.91-0.49-0.86-0.431.0-0.02-0.480.14-0.56-0.560.910.55-0.54
0.640.610.20.81-0.75-0.69-0.760.440.81-0.43-0.37-0.03-0.11-0.410.810.6-0.6-0.730.92
-0.88-0.210.51-0.830.890.910.88-0.48-0.831.0-0.37-0.02-0.530.1-0.51-0.540.910.51-0.48
-0.090.15-0.010.00.00.050.010.170.0-0.02-0.03-0.02-0.18-0.380.130.190.02-0.150.02
0.56-0.13-0.860.23-0.3-0.44-0.280.340.22-0.48-0.11-0.53-0.180.61-0.010.27-0.6-0.01-0.25
-0.02-0.37-0.51-0.340.270.130.28-0.04-0.340.14-0.410.1-0.380.61-0.48-0.210.030.45-0.58
0.610.830.140.78-0.74-0.66-0.740.710.78-0.560.81-0.510.13-0.01-0.480.84-0.61-0.980.82
0.640.87-0.120.66-0.66-0.64-0.640.940.66-0.560.6-0.540.190.27-0.210.84-0.64-0.840.55
-0.97-0.290.57-0.880.930.970.92-0.58-0.880.91-0.60.910.02-0.60.03-0.61-0.640.6-0.55
-0.56-0.82-0.1-0.710.710.630.71-0.77-0.710.55-0.730.51-0.15-0.010.45-0.98-0.840.6-0.73
0.610.620.340.87-0.79-0.69-0.80.350.87-0.540.92-0.480.02-0.25-0.580.820.55-0.55-0.73
Click cells to compare fundamentals

Arch Biopartners Account Relationship Matchups

Arch Biopartners income statement Accounts

202020212022202320242025 (projected)
Depreciation And Amortization4.4M819.4K309.3K2.9M3.3M3.5M
Total Revenue67.9K3.9M964.7K2.0M2.3M2.4M
Gross Profit(2.1M)(149.8K)(502.9K)(129.0K)(116.1K)(121.9K)
Other Operating Expenses4.5M891.5K1.1M5.2M6.0M6.3M
Operating Income(4.6M)(1.2M)(1.1M)(5.2M)(4.7M)(4.5M)
Ebit(8.8M)(1.7M)(1.1M)(8.1M)(7.3M)(7.0M)
Ebitda(4.5M)(891.5K)(1.1M)(5.2M)(4.7M)(4.5M)
Cost Of Revenue2.2M4.0M1.5M2.1M2.4M1.3M
Total Operating Expenses4.5M891.5K1.1M5.2M6.0M6.3M
Income Before Tax(4.6M)(1.2M)(1.4M)(3.6M)(3.2M)(3.1M)
Total Other Income Expense Net5.4K(4.9K)(18.5K)1.7M1.9M2.0M
Net Income(4.6M)(1.2M)(1.4M)(3.3M)(3.0M)(2.8M)
Income Tax Expense(30.3K)36.7K(309.3K)(264.1K)(237.7K)(225.8K)
Selling General Administrative2.5M959.4K772.6K382.0K439.3K763.7K
Selling And Marketing Expenses60.5K41.1K19.7K7.2K6.5K6.1K
Interest Expense176.0K273.3K309.3K358.9K412.8K433.4K
Research Development2.0M3.8M1.3M2.2M2.5M2.7M
Net Income From Continuing Ops(4.6M)(1.2M)(1.4M)(3.3M)(3.0M)(3.1M)
Net Income Applicable To Common Shares(2.1M)(4.6M)(1.2M)(1.4M)(1.3M)(1.3M)
Net Interest Income(176.0K)(273.3K)(309.3K)(342.4K)(308.2K)(292.8K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arch Stock Analysis

When running Arch Biopartners' price analysis, check to measure Arch Biopartners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Biopartners is operating at the current time. Most of Arch Biopartners' value examination focuses on studying past and present price action to predict the probability of Arch Biopartners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Biopartners' price. Additionally, you may evaluate how the addition of Arch Biopartners to your portfolios can decrease your overall portfolio volatility.